{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:02:16Z","timestamp":1789704136297,"version":"4.0.1"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Patients receiving maintenance hemodialysis experience an exceptionally high cardiovascular risk, characterized by frequent recurrent events and a longstanding lack of effective preventive therapies. Most cardiovascular trials in this population have yielded neutral results, highlighting important limitations in both therapeutic strategies and outcome assessment.<\/jats:p>\n                  <jats:p>The PISCES trial recently reported significant reductions in both first and recurrent cardiovascular events with high-dose omega-3 fatty acids in patients undergoing hemodialysis, using a recurrent-event framework to capture overall cardiovascular burden. In this focused narrative review, we critically appraise the PISCES findings within the broader context of omega-3 research in chronic kidney disease and dialysis. Particular emphasis is placed on how biological exposure, population selection, and outcome frameworks influence the detectability of cardiovascular benefit in high-risk populations.<\/jats:p>\n                  <jats:p>PISCES challenges the prevailing notion that cardiovascular risk in hemodialysis is largely unmodifiable and underscores the importance of aligning therapeutic interventions with outcome measures that reflect total disease burden. More broadly, the trial illustrates how methodological choices may critically influence the interpretation of cardiovascular efficacy in populations with dense event clustering and high competing mortality.<\/jats:p>","DOI":"10.1093\/ckj\/sfag118","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:39:18Z","timestamp":1776253158000},"source":"Crossref","is-referenced-by-count":2,"title":["Interpreting the PISCES trial on fish oil in hemodialysis patients: lessons on trial design, biological exposure, and outcome measurement"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6548-0805","authenticated-orcid":false,"given":"Jaime","family":"Maz\u00f3n-Ruiz","sequence":"first","affiliation":[{"name":"Hospital Carmen y Severo Ochoa Nephrology Department, , Cangas del Narcea ,","place":["Spain"]},{"name":"Hospital Universitario Central de Asturias Nephrology Department, , Oviedo ,","place":["Spain"]},{"name":"University of Oviedo Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4027-8467","authenticated-orcid":false,"given":"Marina","family":"de\u00a0Cos\u00a0Gomez","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York Division of Nephrology, Department of Medicine, , NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gonz\u00e1lez\u00a0Bores","sequence":"additional","affiliation":[{"name":"Hospital Universitario de Sierrallana Department of Internal Medicine. , Torrelavega ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-8725","authenticated-orcid":false,"given":"Pablo","family":"Corral","sequence":"additional","affiliation":[{"name":"Universidad FASTA, Clinical Researcher at the Clinical Research Institute (IIC) Department of Pharmacology, Faculty of Medicine, , Mar de Plata ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026050608320341600_bib1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2513032","article-title":"Fish-oil supplementation and cardiovascular events in patients receiving hemodialysis","volume":"394","author":"Lok","year":"2026","journal-title":"N Engl J Med"},{"key":"2026050608320341600_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJMe2515057","article-title":"Fish oil for patients receiving hemodialysis\u2014red herring or great catch?","volume":"394","author":"McCausland","year":"2026","journal-title":"N Engl J Med"},{"key":"2026050608320341600_bib3","doi-asserted-by":"publisher","first-page":"102149","DOI":"10.1016\/j.jacadv.2025.102149","article-title":"Effects of eicosapentaenoic acid vs eicosapentaenoic plus docosahexaenoic acids on cardiovascular outcomes: meta-analysis of randomized trials","volume":"4","author":"Sheppard","year":"2025","journal-title":"JACC Adv"},{"key":"2026050608320341600_bib4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.clnu.2019.02.041","article-title":"Effects of omega-3 polyunsaturated fatty acid intake in CKD: systematic review and meta-analysis","volume":"39","author":"Saglimbene","year":"2020","journal-title":"Clin Nutr"},{"key":"2026050608320341600_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.mayocp.2020.08.034","article-title":"Omega-3 supplementation and cardiovascular outcomes: systematic review and meta-analysis","volume":"96","author":"Bernasconi","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026050608320341600_bib6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on coronary events (JELIS)","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"2026050608320341600_bib7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl (REDUCE-IT)","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"2026050608320341600_bib8","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ki.2013.4","article-title":"Long-chain n-3 fatty acids and sudden cardiac death in hemodialysis","volume":"83","author":"Friedman","year":"2013","journal-title":"Kidney Int"},{"key":"2026050608320341600_bib9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.jrn.2025.02.001","article-title":"Low plasma marine n-3 fatty acids and cardiovascular risk in maintenance hemodialysis","volume":"35","author":"Liboriussen","year":"2025","journal-title":"J Ren Nutr"},{"key":"2026050608320341600_bib10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCULATIONAHA.122.059410","article-title":"Effects of icosapent ethyl and mineral-oil comparator on inflammatory biomarkers","volume":"146","author":"Ridker","year":"2022","journal-title":"Circulation"},{"key":"2026050608320341600_bib11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCULATIONAHA.121.054539","article-title":"Questioning the placebo in REDUCE-IT","volume":"144","author":"Bostrom","year":"2021","journal-title":"Circulation"},{"key":"2026050608320341600_bib12","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/ckj\/sfad029","article-title":"Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study","volume":"16","author":"Marx","year":"2023","journal-title":"Clin Kidney J"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag118\/68093707\/sfag118.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag118\/68093707\/sfag118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag118\/68093707\/sfag118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:32:06Z","timestamp":1778070726000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag118\/8655897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag118","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,16]]},"article-number":"sfag118"}}